Carregant...
Polyomavirus-driven Merkel cell carcinoma: prospects for therapeutic vaccine development
Great strides have been made in cancer immunotherapy including the breakthrough successes of anti-PD-(L)1 checkpoint inhibitors. In Merkel cell carcinoma (MCC), a rare and aggressive skin cancer, PD-(L)1 blockade is highly effective. Yet, ~50% of patients either do not respond to therapy or develop...
Guardat en:
| Publicat a: | Mol Carcinog |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8238237/ https://ncbi.nlm.nih.gov/pubmed/32219902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.23190 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|